Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $9.19 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.90.
Market Cap
9.19T
Revenue
4.67T
Profits
188.01B
PE Ratio
48.90
Profit Margin
4.03%
Dividend Yield
0.38%
1049 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.00T | -2.21% | 2,220,270 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 648.55B | -2.22% | 4,320,878 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 439.62B | -2.99% | 4,729,800 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 366.28B | -1.24% | 4,397,467 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 359.79B | 0.93% | 5,566,518 | 450.53B |
| 6 | NVS | Novartis AG | 262.71B | -13.93% | 1,294,324 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 249.53B | -1.63% | 3,073,349 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 222.97B | -1.75% | 1,229,134 | 46.34B |
| 9 | AMGN | Amgen Inc. | 212.56B | -10.08% | 1,656,089 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 200.93B | -3.09% | 6,219,243 | 50.34B |
| 11 | ABT | Abbott Laboratories | 182.59B | -2.59% | 7,029,454 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 181.83B | -2.89% | 6,181,783 | 30.46B |
| 13 | PFE | Pfizer Inc. | 158.39B | -2.32% | 23,791,956 | 63.70B |
| 14 | DHR | Danaher Corporation | 144.27B | -1.17% | 2,898,175 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 134.06B | -3.15% | 803,524 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 132.14B | -3.19% | 4,825,447 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 123.70B | -4.51% | 2,081,783 | 11.03B |
| 18 | CVS | CVS Health Corporation | 122.87B | -0.69% | 4,499,060 | 412.65B |
| 19 | MDT | Medtronic plc | 118.18B | -1.89% | 9,013,901 | 37.54B |
| 20 | SYK | Stryker Corporation | 106.03B | -8.81% | 2,401,462 | 25.84B |
| 21 | SNY | Sanofi | 104.09B | -2.45% | 1,695,047 | 55.89B |
| 22 | MCK | McKesson Corporation | 103.66B | -2.08% | 879,268 | 410.98B |
| 23 | GSK | GSK plc | 97.52B | -2.71% | 2,287,091 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 87.17B | -1.36% | 1,132,883 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 87.04B | -0.74% | 971,432 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.91B | -2.10% | 556,427 | 15.53B |
| 27 | CI | The Cigna Group | 72.89B | -1.83% | 1,204,767 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 65.19B | -5.90% | 15,504,234 | 21.00B |
| 29 | ARGX | argenx SE | 62.97B | -2.52% | 125,058 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.96B | -1.89% | 1,027,638 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.65B | -0.70% | 1,499,547 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 56.02B | -3.59% | 14,966,547 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 55.93B | -2.71% | 1,548,359 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 49.99B | -3.54% | 2,635,295 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 48.78B | -3.05% | 1,439,133 | 22.48B |
| 36 | HUM | Humana Inc. | 48.40B | 0.39% | 783,104 | 145.68B |
| 37 | NTRA | Natera, Inc. | 46.72B | -1.23% | 968,221 | 2.71B |
| 38 | MDLN | Medline Inc. | 45.61B | -5.19% | 5,244,069 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 44.44B | -1.29% | 885,061 | - |
| 40 | VEEV | Veeva Systems Inc. | 42.88B | -3.73% | 1,152,403 | 3.46B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 42.84B | 1.10% | 7,402,523 | 17.32B |
| 42 | IQV | IQVIA Holdings Inc. | 42.67B | -3.20% | 1,197,936 | 16.98B |
| 43 | A | Agilent Technologies, Inc. | 41.40B | -2.66% | 1,825,450 | 7.37B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 40.98B | -2.83% | 407,845 | 4.55B |
| 45 | HLN | Haleon plc | 40.25B | -3.65% | 18,166,343 | 14.80B |
| 46 | ONC | BeOne Medicines AG | 39.96B | -1.89% | 202,358 | 6.13B |
| 47 | WAT | Waters Corporation | 39.59B | -1.58% | 352,082 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 34.84B | -5.27% | 3,402,567 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.80B | -2.26% | 1,431,221 | 4.80B |
| 50 | ALC | Alcon Inc. | 33.36B | -1.96% | 1,341,022 | 10.86B |
| 51 | CNC | Centene Corporation | 31.90B | -3.67% | 2,926,371 | 180.30B |
| 52 | DXCM | DexCom, Inc. | 31.90B | -3.83% | 2,361,537 | 4.97B |
| 53 | ILMN | Illumina, Inc. | 31.87B | -3.28% | 1,748,198 | 4.49B |
| 54 | RMD | ResMed Inc. | 31.62B | -3.20% | 843,837 | 5.65B |
| 55 | BIIB | Biogen Inc. | 31.40B | -3.77% | 465,108 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 30.40B | -2.97% | 4,170,458 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 30.16B | -3.03% | 2,812,732 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 29.96B | 18.75% | 5,240,613 | 7.53M |
| 59 | INSM | Insmed Incorporated | 27.27B | -1.11% | 1,802,693 | 1.14B |
| 60 | MTD | Mettler-Toledo International Inc. | 26.56B | -1.47% | 103,033 | 4.13B |
| 61 | LH | Labcorp Holdings Inc. | 26.35B | -0.62% | 438,651 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 25.99B | -0.69% | 798,704 | 11.56B |
| 63 | INCY | Incyte Corporation | 25.22B | -1.85% | 1,036,073 | 5.82B |
| 64 | PHG | Koninklijke Philips N.V. | 24.85B | -2.32% | 455,476 | 20.18B |
| 65 | BNTX | BioNTech SE | 24.78B | -4.92% | 626,059 | 3.03B |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.77B | -0.65% | 364,084 | 3.33B |
| 67 | GH | Guardant Health, Inc. | 21.60B | -0.27% | 2,402,454 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.36B | 2.12% | 327,024 | 3.15B |
| 69 | STE | STERIS plc | 21.30B | -2.74% | 567,998 | 6.04B |
| 70 | THC | Tenet Healthcare Corporation | 20.86B | -2.26% | 557,693 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.11B | -0.21% | 1,002,605 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.08B | -1.60% | 5,732,791 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.97B | -3.93% | 1,325,048 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.74B | -0.17% | 723,515 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.49B | -0.07% | 146,430 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 15.77B | -0.33% | 933,569 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.58B | -2.73% | 321,869 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.34B | -1.72% | 576,350 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.62B | -0.11% | 1,539,365 | 713.07M |
| 80 | EXEL | Exelixis, Inc. | 14.29B | -2.27% | 2,538,923 | 2.44B |
| 81 | RVTY | Revvity, Inc. | 14.18B | -2.41% | 1,496,185 | 2.91B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.79B | -1.87% | 6,946,115 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.40B | -2.68% | 738,889 | 4.00B |
| 84 | COO | The Cooper Companies, Inc. | 13.20B | -2.73% | 1,957,081 | 4.23B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 13.03B | 3.01% | 3,210,719 | 14.37B |
| 86 | BAX | Baxter International Inc. | 12.85B | -3.76% | 3,415,196 | 11.47B |
| 87 | PEN | Penumbra, Inc. | 12.58B | -0.90% | 380,767 | 1.50B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 12.51B | -2.86% | 1,457,585 | 3.41B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.34B | -1.28% | 177,171 | 1.28B |
| 90 | CORT | Corcept Therapeutics Incorporated | 12.32B | 2.11% | 604,556 | 830.81M |
| 91 | HALO | Halozyme Therapeutics, Inc. | 12.29B | -1.71% | 1,010,602 | 1.66B |
| 92 | ICLR | ICON Public Limited Company | 12.22B | -3.95% | 796,396 | 8.29B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.02B | -1.42% | 757,847 | 669.50M |
| 94 | ELAN | Elanco Animal Health Incorporated | 11.98B | -2.16% | 3,718,067 | 5.02B |
| 95 | FMS | Fresenius Medical Care AG | 11.96B | -0.93% | 480,312 | 22.19B |
| 96 | EHC | Encompass Health Corporation | 11.88B | -1.08% | 517,750 | 6.21B |
| 97 | SNN | Smith & Nephew plc | 11.69B | -3.46% | 851,037 | 6.30B |
| 98 | TEM | Tempus AI, Inc. | 11.60B | -0.51% | 4,574,980 | 1.43B |
| 99 | DVA | DaVita Inc. | 11.48B | -2.14% | 473,725 | 14.01B |
| 100 | TECH | Bio-Techne Corporation | 11.34B | -0.17% | 1,856,314 | 1.22B |
| 101 | GKOS | Glaukos Corporation | 10.91B | 4.27% | 1,158,564 | 612.84M |
| 102 | ALGN | Align Technology, Inc. | 10.90B | -3.25% | 990,518 | 4.14B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.89B | 0.55% | 438,242 | 776.57M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.48B | 3.62% | 1,920,948 | 67.67M |
| 105 | KRYS | Krystal Biotech, Inc. | 10.40B | -1.95% | 323,022 | 440.48M |
| 106 | AVTR | Avantor, Inc. | 10.31B | 1.87% | 7,654,022 | 6.56B |
| 107 | ABVX | ABIVAX Société Anonyme | 10.24B | 3.62% | 489,816 | 5.67M |
| 108 | MOH | Molina Healthcare, Inc. | 10.23B | -2.24% | 258,291 | 42.47B |
| 109 | OSCR | Oscar Health, Inc. | 10.18B | 2.36% | 3,689,944 | 15.32B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.16B | -1.55% | 112,950 | 2.59B |
| 111 | UHS | Universal Health Services, Inc. | 10.13B | 1.32% | 428,933 | 18.11B |
| 112 | RDY | Dr. Reddy's Laboratories Limited | 10.12B | -0.75% | 2,343,590 | 3.50B |
| 113 | GMED | Globus Medical, Inc. | 10.08B | -4.15% | 1,123,661 | 3.14B |
| 114 | HSIC | Henry Schein, Inc. | 9.90B | -1.06% | 887,873 | 13.60B |
| 115 | PODD | Insulet Corporation | 9.87B | -3.53% | 1,058,435 | 3.05B |
| 116 | ENSG | The Ensign Group, Inc. | 9.86B | -0.15% | 270,479 | 5.49B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.84B | 0.19% | 175,356 | 7.46M |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.68B | -0.78% | 378,568 | 105.00M |
| 119 | RGEN | Repligen Corporation | 9.51B | 0.55% | 806,066 | 785.10M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.44B | 0.15% | 635,396 | 281.99M |
| 121 | IONS | Ionis Pharmaceuticals, Inc. | 9.42B | -2.38% | 2,671,092 | 874.09M |
| 122 | PCVX | Vaxcyte, Inc. | 8.98B | -1.31% | 986,706 | - |
| 123 | BRKR | Bruker Corporation | 8.89B | -0.22% | 1,334,184 | 3.50B |
| 124 | IBRX | ImmunityBio, Inc. | 8.79B | 2.60% | 4,330,218 | 165.79M |
| 125 | QGEN | Qiagen N.V. | 8.76B | -2.51% | 1,922,422 | 2.10B |
| 126 | TXG | 10x Genomics, Inc. | 8.55B | 4.71% | 1,469,824 | 616.91M |
| 127 | IMVT | Immunovant, Inc. | 8.17B | 0.82% | 765,742 | - |
| 128 | TWST | Twist Bioscience Corporation | 8.03B | 2.68% | 1,805,769 | 431.80M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.01B | 2.03% | 803,857 | - |
| 130 | TGTX | TG Therapeutics, Inc. | 7.91B | -0.45% | 992,966 | 799.54M |
| 131 | ATR | AptarGroup, Inc. | 7.91B | -2.41% | 323,986 | 3.93B |
| 132 | BLTE | Belite Bio, Inc | 7.77B | -0.39% | 738,953 | - |
| 133 | HQY | HealthEquity, Inc. | 7.72B | -2.82% | 432,485 | 1.36B |
| 134 | ALKS | Alkermes plc | 7.63B | -1.32% | 1,354,284 | 1.67B |
| 135 | HNGE | Hinge Health, Inc. | 7.48B | 0.35% | 1,179,523 | 720.06M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.01B | -1.00% | 4,584,141 | 989.61M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.01B | -0.91% | 512,487 | 239.92M |
| 138 | SRRK | Scholar Rock Holding Corporation | 6.99B | 3.78% | 658,048 | - |
| 139 | GRFS | Grifols, S.A. | 6.94B | -0.64% | 157,911 | 8.48B |
| 140 | PACS | PACS Group, Inc. | 6.91B | 2.75% | 649,463 | 5.55B |
| 141 | CHE | Chemed Corporation | 6.75B | -0.16% | 132,296 | 2.60B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.57B | 1.66% | 7,181,866 | 2.58B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.56B | -0.52% | 859,896 | 1.56B |
| 144 | MMED | MiniMed Group, Inc. | 6.55B | 0.13% | 1,719,503 | 3.22B |
| 145 | CGON | CG Oncology, Inc. | 6.51B | -1.70% | 282,523 | 6.23M |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.46B | -1.36% | 350,960 | 618.07M |
| 147 | BLCO | Bausch + Lomb Corporation | 6.33B | -1.72% | 335,603 | 5.32B |
| 148 | ORKA | Oruka Therapeutics, Inc. | 6.24B | 1.95% | 600,471 | - |
| 149 | TVTX | Travere Therapeutics, Inc. | 6.23B | 1.21% | 1,050,705 | 591.33M |
| 150 | COGT | Cogent Biosciences, Inc. | 6.12B | 1.50% | 784,080 | - |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 6.10B | 0.95% | 638,559 | 1.90M |
| 152 | LQDA | Liquidia Corporation | 6.06B | -1.43% | 902,384 | 450.91M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.01B | -1.05% | 430,045 | 840.85M |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 5.94B | -2.24% | 1,440,974 | 3.12B |
| 155 | TFX | Teleflex Incorporated | 5.81B | -0.98% | 464,473 | 2.25B |
| 156 | XENE | Xenon Pharmaceuticals Inc. | 5.77B | -0.33% | 459,231 | 7.50M |
| 157 | LGND | Ligand Pharmaceuticals Incorporated | 5.76B | 1.13% | 132,389 | 290.54M |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.74B | -0.71% | 1,117,611 | 1.01B |
| 159 | ERAS | Erasca, Inc. | 5.69B | 0.56% | 4,264,651 | - |
| 160 | RDNT | RadNet, Inc. | 5.66B | -2.36% | 448,768 | 2.27B |
| 161 | STVN | Stevanato Group S.p.A. | 5.55B | -0.93% | 212,893 | 1.40B |
| 162 | SHC | Sotera Health Company | 5.31B | -1.64% | 1,215,652 | 1.22B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.30B | -1.81% | 904,292 | 13.39M |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.22B | -2.48% | 599,642 | 1.58B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.14B | 0.37% | 1,494,398 | - |
| 166 | PBLS | Parabilis Medicines, Inc. | 4.91B | -1.61% | 380,843 | 148.00K |
| 167 | LFST | LifeStance Health Group, Inc. | 4.89B | 0.55% | 3,071,372 | 1.58B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.76B | 1.74% | 826,754 | - |
| 169 | ACAD | ACADIA Pharmaceuticals Inc. | 4.75B | -1.57% | 1,682,950 | 1.14B |
| 170 | HAE | Haemonetics Corporation | 4.68B | -0.08% | 581,579 | 1.35B |
| 171 | BLLN | BillionToOne, Inc. | 4.67B | -0.33% | 976,446 | 397.41M |
| 172 | WAY | Waystar Holding Corp. | 4.65B | -3.31% | 893,703 | 1.21B |
| 173 | CELC | Celcuity Inc. | 4.55B | -2.80% | 515,520 | - |
| 174 | LIVN | LivaNova PLC | 4.45B | -1.49% | 334,168 | 1.47B |
| 175 | DOCS | Doximity, Inc. | 4.35B | -7.32% | 1,984,710 | 655.57M |
| 176 | ELVN | Enliven Therapeutics, Inc. | 4.35B | 0.08% | 1,113,062 | - |
| 177 | MANE | Veradermics, Incorporated | 4.34B | 5.40% | 363,236 | - |
| 178 | CON | Concentra Group Holdings Parent, Inc. | 4.32B | -1.71% | 363,452 | 2.29B |
| 179 | NVST | Envista Holdings Corporation | 4.31B | -1.72% | 1,682,157 | 2.86B |
| 180 | ITGR | Integer Holdings Corporation | 4.29B | -0.24% | 1,610,993 | 1.84B |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.25B | -0.65% | 885,518 | -665.00K |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.19B | 0.37% | 2,054,847 | 10.35M |
| 183 | HTFL | HeartFlow, Inc. | 4.15B | -2.37% | 1,407,076 | 212.07M |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.05B | -1.77% | 1,019,385 | 1.33B |
| 185 | TLX | Telix Pharmaceuticals Limited | 4.05B | 0.34% | 142,006 | 890.79M |
| 186 | IRTC | iRhythm Holdings, Inc. | 4.03B | -0.67% | 444,543 | 825.34M |
| 187 | ICUI | ICU Medical, Inc. | 4.02B | -3.99% | 163,496 | 2.16B |
| 188 | LEGN | Legend Biotech Corporation | 3.97B | -4.79% | 812,413 | 1.27B |
| 189 | IOVA | Iovance Biotherapeutics, Inc. | 3.94B | -1.02% | 8,079,575 | 324.97M |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.93B | -3.41% | 1,402,465 | - |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.88B | 0.25% | 1,404,316 | 308.08M |
| 192 | TARS | Tarsus Pharmaceuticals, Inc. | 3.83B | -3.92% | 1,595,936 | 606.33M |
| 193 | TNGX | Tango Therapeutics, Inc. | 3.83B | 0.80% | 2,424,926 | 53.81M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.79B | -16.35% | 1,588,059 | - |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.75B | -2.56% | 448,007 | 234.13M |
| 196 | ABCL | AbCellera Biologics Inc. | 3.71B | 0.09% | 2,019,253 | 66.17M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.70B | -2.02% | 1,363,073 | 117.00M |
| 198 | OGN | Organon & Co. | 3.61B | -0.22% | 4,872,489 | 6.13B |
| 199 | OPCH | Option Care Health, Inc. | 3.56B | -1.94% | 1,155,767 | 5.69B |
| 200 | GRAL | GRAIL, Inc. | 3.53B | -1.54% | 434,820 | 165.26M |
| 201 | DNLI | Denali Therapeutics Inc. | 3.53B | -0.90% | 799,633 | 3.60M |
| 202 | PLSE | Pulse Biosciences, Inc. | 3.48B | -8.36% | 515,419 | 1.19M |
| 203 | NHC | National HealthCare Corporation | 3.46B | 1.07% | 61,029 | 1.56B |
| 204 | VCYT | Veracyte, Inc. | 3.41B | -0.19% | 992,183 | 561.90M |
| 205 | RGC | Regencell Bioscience Holdings Limited | 3.38B | -1.02% | 659,354 | - |
| 206 | QURE | uniQure N.V. | 3.17B | 2.65% | 991,475 | 18.67M |
| 207 | CLDX | Celldex Therapeutics, Inc. | 3.07B | -1.41% | 833,635 | 158.00K |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 3.07B | 2.05% | 1,631,999 | 463.98M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.06B | 0.91% | 709,503 | 7.12M |
| 210 | TMDX | TransMedics Group, Inc. | 3.06B | -1.90% | 542,804 | 668.47M |
| 211 | WRBY | Warby Parker Inc. | 3.06B | 1.68% | 3,054,452 | 911.61M |
| 212 | IMNM | Immunome, Inc. | 3.05B | 0.19% | 562,401 | 4.02M |
| 213 | MBX | MBX Biosciences, Inc. | 3.03B | 2.06% | 265,954 | - |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.98B | 0.59% | 5,450,863 | 2.60B |
| 215 | IRON | Disc Medicine, Inc. | 2.95B | -3.02% | 204,857 | - |
| 216 | BKD | Brookdale Senior Living Inc. | 2.89B | 2.72% | 3,222,764 | 2.93B |
| 217 | GPCR | Structure Therapeutics Inc. | 2.88B | -14.70% | 281,709 | - |
| 218 | ZLAB | Zai Lab Limited | 2.85B | -3.13% | 711,747 | 449.61M |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | 2.82B | 0.72% | 4,526,880 | - |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.79B | -0.59% | 5,101,083 | 4.58B |
| 221 | MLYS | Mineralys Therapeutics, Inc. | 2.75B | 10.32% | 643,518 | - |
| 222 | ATRC | AtriCure, Inc. | 2.73B | 4.29% | 714,569 | 569.62M |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.71B | -0.04% | 1,232,151 | 36.77M |
| 224 | ATAI | AtaiBeckley Inc. | 2.70B | -1.49% | 10,313,859 | 4.47M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.69B | 4.12% | 653,101 | 1.46B |
| 226 | BEAM | Beam Therapeutics Inc. | 2.68B | -9.54% | 1,183,164 | 156.04M |
| 227 | PHVS | Pharvaris N.V. | 2.66B | 7.35% | 483,983 | - |
| 228 | PRVA | Privia Health Group, Inc. | 2.65B | 0.58% | 869,322 | 2.36B |
| 229 | VRDN | Viridian Therapeutics, Inc. | 2.62B | 1.09% | 759,915 | 71.13M |
| 230 | CDNA | CareDx, Inc. | 2.60B | -1.12% | 1,307,394 | 458.09M |
| 231 | NEOG | Neogen Corporation | 2.59B | 0.46% | 1,263,005 | 870.40M |
| 232 | NKTR | Nektar Therapeutics | 2.58B | 1.68% | 607,432 | 54.59M |
| 233 | WGS | GeneDx Holdings Corp. | 2.56B | -0.14% | 426,646 | 454.43M |
| 234 | ACHC | Acadia Healthcare Company, Inc. | 2.56B | -2.24% | 835,044 | 3.37B |
| 235 | VERA | Vera Therapeutics, Inc. | 2.54B | -1.70% | 1,184,658 | - |
| 236 | AXGN | Axogen, Inc. | 2.51B | -3.29% | 550,070 | 251.17M |
| 237 | OCUL | Ocular Therapeutix, Inc. | 2.50B | 6.86% | 2,737,328 | 52.06M |
| 238 | SUPN | Supernus Pharmaceuticals, Inc. | 2.47B | -2.53% | 429,134 | 830.44M |
| 239 | PGEN | Precigen, Inc. | 2.46B | -3.24% | 2,192,987 | 85.72M |
| 240 | HRMY | Harmony Biosciences Holdings, Inc. | 2.45B | -0.43% | 662,547 | 959.90M |
| 241 | BHC | Bausch Health Companies Inc. | 2.40B | -1.98% | 1,652,776 | 10.85B |
| 242 | HCM | HUTCHMED (China) Limited | 2.40B | -1.49% | 150,499 | 549.12M |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.40B | -2.55% | 856,672 | - |
| 244 | TRLV | Trulieve Cannabis Corp. | 2.39B | 2.64% | 1,371,949 | 1.14B |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.36B | -4.73% | 417,979 | 1.10B |
| 246 | NUVB | Nuvation Bio Inc. | 2.32B | -2.94% | 3,755,288 | 169.90M |
| 247 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.32B | -8.99% | 1,495,739 | 940.61M |
| 248 | CLOV | Clover Health Investments, Corp. | 2.28B | 0.82% | 2,065,895 | 2.48B |
| 249 | NEO | NeoGenomics, Inc. | 2.26B | 1.04% | 997,013 | 766.30M |
| 250 | ESTA | Establishment Labs Holdings Inc. | 2.24B | 1.35% | 433,598 | 245.82M |
| 251 | BHVN | Biohaven Ltd. | 2.22B | -6.18% | 3,306,519 | - |
| 252 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | -6.93% | 2,955,533 | 1.97B |
| 253 | RAPP | Rapport Therapeutics, Inc. | 2.21B | 0.70% | 489,112 | 20.00M |
| 254 | KOD | Kodiak Sciences Inc. | 2.20B | -0.82% | 675,921 | - |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.19B | -3.15% | 162,268 | - |
| 256 | XRAY | DENTSPLY SIRONA Inc. | 2.19B | -3.43% | 2,600,972 | 3.64B |
| 257 | ADUS | Addus HomeCare Corporation | 2.18B | 0.47% | 177,120 | 1.48B |
| 258 | UFPT | UFP Technologies, Inc. | 2.18B | -2.62% | 117,277 | 631.64M |
| 259 | ZBIO | Zenas BioPharma, Inc. | 2.15B | 0.52% | 452,691 | 1.00M |
| 260 | MESO | Mesoblast Limited | 2.15B | -5.37% | 151,379 | 120.25M |
| 261 | URGN | UroGen Pharma Ltd. | 2.14B | -0.62% | 727,715 | 188.73M |
| 262 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.06% | 526,594 | 311.51M |
| 263 | MD | Pediatrix Medical Group, Inc. | 2.14B | -0.33% | 532,946 | 1.95B |
| 264 | ADMA | ADMA Biologics, Inc. | 2.14B | -0.83% | 1,405,858 | 512.28M |
| 265 | KLRA | Kailera Therapeutics, Inc. | 2.13B | 1.23% | 524,423 | - |
| 266 | PGNY | Progyny, Inc. | 2.08B | 4.66% | 1,057,015 | 1.31B |
| 267 | COAG | Hemab Therapeutics Holdings, Inc. | 2.08B | 0.36% | 302,045 | - |
| 268 | ALMR | Alamar Biosciences, Inc. | 2.08B | -2.76% | 221,436 | 100.42M |
| 269 | GENB | Generate Biomedicines, Inc. | 2.04B | -2.99% | 725,332 | 26.48M |
| 270 | PRGO | Perrigo Company plc | 2.02B | -2.28% | 3,061,977 | 4.14B |
| 271 | KARD | Kardigan, Inc. | 2.02B | 3.60% | 279,615 | - |
| 272 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 1.36% | 815,750 | 98.34M |
| 273 | BFLY | Butterfly Network, Inc. | 2.00B | 2.17% | 3,050,577 | 112.14M |
| 274 | VCEL | Vericel Corporation | 2.00B | -2.76% | 312,914 | 306.30M |
| 275 | ZYME | Zymeworks Inc. | 1.99B | -3.70% | 443,267 | 37.13M |
| 276 | NVCR | NovoCure Limited | 1.96B | -6.08% | 732,170 | 699.19M |
| 277 | ASTH | Astrana Health, Inc. | 1.95B | -0.96% | 241,953 | 3.84B |
| 278 | CMPS | COMPASS Pathways plc | 1.94B | 5.80% | 794,907 | - |
| 279 | STOK | Stoke Therapeutics, Inc. | 1.94B | 0.84% | 680,491 | 27.59M |
| 280 | NBTX | Nanobiotix S.A. | 1.92B | -1.57% | 119,297 | 38.27M |
| 281 | GHRS | GH Research PLC | 1.91B | -1.56% | 221,033 | - |
| 282 | VIR | Vir Biotechnology, Inc. | 1.89B | -1.84% | 1,613,922 | 303.23M |
| 283 | BRVE | Braveheart Bio, Inc. | 1.89B | 9.99% | 613,249 | - |
| 284 | XNCR | Xencor, Inc. | 1.88B | -4.81% | 1,237,711 | 104.97M |
| 285 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | -1.78% | 1,552,057 | 208.78M |
| 286 | ALVO | Alvotech | 1.85B | -2.44% | 535,401 | 494.61M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.85B | 3.63% | 755,451 | 481.07M |
| 288 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -5.23% | 29,039,059 | 54.86M |
| 289 | IMCR | Immunocore Holdings plc | 1.82B | -2.13% | 231,712 | 430.78M |
| 290 | LMAT | LeMaitre Vascular, Inc. | 1.82B | -1.34% | 167,362 | 262.43M |
| 291 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -3.02% | 208,178 | 1.13B |
| 292 | SGRY | Surgery Partners, Inc. | 1.81B | -2.10% | 1,106,623 | 3.37B |
| 293 | DMRA | Damora Therapeutics, Inc. | 1.80B | -2.96% | 295,832 | - |
| 294 | INSP | Inspire Medical Systems, Inc. | 1.80B | -1.49% | 425,723 | 898.74M |
| 295 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -2.14% | 2,111,279 | 5.49M |
| 296 | NTLA | Intellia Therapeutics, Inc. | 1.79B | - | 2,796,288 | 59.51M |
| 297 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | -3.02% | 1,204,109 | 252.25M |
| 298 | PSNL | Personalis, Inc. | 1.77B | -3.49% | 2,522,867 | 69.67M |
| 299 | SEPN | Septerna, Inc. | 1.74B | 1.69% | 309,699 | 98.88M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.73B | 0.37% | 788,033 | 106.69M |
| 301 | FRNM | Freenome, Inc. | 1.72B | -1.96% | 541,575 | 35.41M |
| 302 | ETON | Eton Pharmaceuticals, Inc. | 1.70B | 1.53% | 521,603 | 105.60M |
| 303 | INBX | Inhibrx Biosciences, Inc. | 1.68B | -5.64% | 196,513 | 1.30M |
| 304 | NVAX | Novavax, Inc. | 1.68B | -0.29% | 5,125,027 | 413.80M |
| 305 | ANAB | AnaptysBio, Inc. | 1.68B | -0.35% | 1,061,882 | 232.39M |
| 306 | AVLN | Avalyn Pharma Inc. | 1.67B | 0.62% | 243,509 | - |
| 307 | FTRE | Fortrea Holdings Inc. | 1.62B | -3.62% | 762,079 | 2.68B |
| 308 | AAPG | Ascentage Pharma Group International | 1.60B | -0.99% | 20,901 | 94.61M |
| 309 | APMD | Apnimed, Inc. | 1.60B | 4.88% | 233,022 | 120.15M |
| 310 | TYRA | Tyra Biosciences, Inc. | 1.60B | -6.70% | 1,158,786 | - |
| 311 | LBRX | LB Pharmaceuticals Inc | 1.59B | 0.10% | 205,964 | - |
| 312 | LTGO | Latigo Biotherapeutics, Inc. | 1.57B | 2.99% | 227,438 | - |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.57B | 2.33% | 296,877 | - |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | -0.59% | 1,030,533 | 335.41M |
| 315 | OMCL | Omnicell, Inc. | 1.55B | -1.43% | 873,122 | 1.25B |
| 316 | INVA | Innoviva, Inc. | 1.54B | 0.05% | 563,508 | 440.00M |
| 317 | AGL | agilon health, inc. | 1.53B | 3.24% | 125,900 | 5.92B |
| 318 | ABSI | Absci Corporation | 1.53B | 1.02% | 2,150,231 | 1.56M |
| 319 | ARDT | Ardent Health, Inc. | 1.52B | -1.47% | 560,996 | 6.41B |
| 320 | PAHC | Phibro Animal Health Corporation | 1.51B | -2.46% | 176,418 | 1.52B |
| 321 | ANIP | ANI Pharmaceuticals, Inc. | 1.50B | -1.40% | 219,218 | 978.38M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | 0.37% | 181,777 | 95.13M |
| 323 | SDGR | Schrödinger, Inc. | 1.50B | -0.30% | 877,064 | 259.04M |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.49B | -0.18% | 593,954 | 1.86B |
| 325 | SLBT | SL Science Holding Limited | 1.49B | -9.03% | 109,232 | 3.27M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -2.16% | 721,632 | - |
| 327 | TRAX | First Tracks Biotherapeutics, Inc. | 1.49B | 3.14% | 456,231 | - |
| 328 | VOR | Vor Biopharma Inc. | 1.48B | 0.20% | 421,763 | - |
| 329 | MAZE | Maze Therapeutics, Inc. | 1.46B | 0.61% | 365,302 | 20.00M |
| 330 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -2.75% | 11,494,472 | 717.00M |
| 331 | INNV | InnovAge Holding Corp. | 1.43B | -2.14% | 161,443 | 949.17M |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.42B | -2.75% | 1,581,073 | 815.05M |
| 333 | HROW | Harrow, Inc. | 1.42B | -1.79% | 229,022 | 275.59M |
| 334 | SVRA | Savara Inc. | 1.41B | 2.98% | 625,457 | - |
| 335 | ANRO | Alto Neuroscience, Inc. | 1.41B | 0.73% | 580,922 | - |
| 336 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | -1.81% | 953,199 | - |
| 337 | CNMD | CONMED Corporation | 1.40B | -5.54% | 331,709 | 1.37B |
| 338 | REPL | Replimune Group, Inc. | 1.39B | -1.80% | 910,229 | - |
| 339 | AKTS | Aktis Oncology, Inc. | 1.39B | -7.50% | 567,224 | 10.06M |
| 340 | OMER | Omeros Corporation | 1.38B | 0.90% | 892,192 | 38.42M |
| 341 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | -0.10% | 1,637,231 | 1.04B |
| 342 | PNTG | The Pennant Group, Inc. | 1.37B | 3.45% | 174,309 | 1.10B |
| 343 | DRTS | Alpha Tau Medical Ltd. | 1.37B | -1.26% | 752,110 | - |
| 344 | ALMS | Alumis Inc. | 1.37B | -4.68% | 3,078,140 | 7.40M |
| 345 | OMDA | Omada Health, Inc. | 1.36B | -2.59% | 877,387 | 309.76M |
| 346 | AZTA | Azenta, Inc. | 1.35B | -1.63% | 1,159,909 | 613.81M |
| 347 | MNKD | MannKind Corporation | 1.34B | 2.46% | 2,807,581 | 393.63M |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.31B | -1.87% | 991,453 | - |
| 349 | AMN | AMN Healthcare Services, Inc. | 1.31B | -0.21% | 494,914 | 3.43B |
| 350 | NUTX | Nutex Health Inc. | 1.31B | -1.34% | 142,279 | 846.72M |
| 351 | MGTX | MeiraGTx Holdings plc | 1.30B | -2.59% | 531,145 | 397.50M |
| 352 | ODTX | Odyssey Therapeutics, Inc. | 1.29B | -6.22% | 268,974 | 99.00K |
| 353 | IMTX | Immatics N.V. | 1.29B | -1.26% | 497,160 | 47.65M |
| 354 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -3.22% | 141,709 | - |
| 355 | MLTX | MoonLake Immunotherapeutics | 1.27B | -0.47% | 1,428,699 | - |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.26B | -2.75% | 674,913 | 1.65B |
| 357 | JBIO | Jade Biosciences, Inc. | 1.24B | -2.26% | 605,018 | - |
| 358 | AORT | Artivion, Inc. | 1.23B | -1.72% | 619,365 | 471.47M |
| 359 | JANX | Janux Therapeutics, Inc. | 1.23B | -0.99% | 700,774 | 24.00M |
| 360 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | -6.20% | 1,276,668 | 337.34M |
| 361 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | 3.11% | 1,197,280 | 28.73M |
| 362 | STAA | STAAR Surgical Company | 1.21B | 2.94% | 1,403,263 | 339.59M |
| 363 | GDRX | GoodRx Holdings, Inc. | 1.20B | 1.15% | 854,870 | 785.23M |
| 364 | OPK | OPKO Health, Inc. | 1.19B | -3.05% | 2,350,122 | 587.90M |
| 365 | CERT | Certara, Inc. | 1.18B | -2.52% | 2,879,942 | 421.75M |
| 366 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -0.81% | 91,804 | 804.27M |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | -3.20% | 626,950 | - |
| 368 | CRON | Cronos Group Inc. | 1.17B | -2.30% | 493,811 | 179.09M |
| 369 | BVS | Bioventus Inc. | 1.16B | -1.71% | 477,909 | 581.85M |
| 370 | OBX | Obsidian Therapeutics, Inc. | 1.16B | 11.36% | 140,120 | - |
| 371 | ENOV | Enovis Corporation | 1.15B | 7.65% | 3,743,670 | 2.30B |
| 372 | TDOC | Teladoc Health, Inc. | 1.14B | -0.32% | 2,957,363 | 2.49B |
| 373 | KURA | Kura Oncology, Inc. | 1.11B | -5.51% | 1,313,519 | 77.23M |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | -5.25% | 250,655 | 1.04B |
| 375 | IVA | Inventiva S.A. | 1.11B | -2.30% | 1,350,616 | 7.94M |
| 376 | ATTO | Attovia Therapeutics, Inc. | 1.08B | -7.40% | 268,136 | 1.80M |
| 377 | IRMD | IRADIMED CORPORATION | 1.08B | 1.14% | 233,294 | 86.34M |
| 378 | GMRS | GMR Solutions Inc. | 1.07B | 2.53% | 803,201 | 5.88B |
| 379 | SLDB | Solid Biosciences Inc. | 1.06B | -3.12% | 495,327 | - |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.06B | 2.50% | 633,230 | 59.00K |
| 381 | SANA | Sana Biotechnology, Inc. | 1.03B | -10.39% | 1,239,920 | - |
| 382 | PCRX | Pacira BioSciences, Inc. | 1.03B | -1.82% | 481,690 | 746.16M |
| 383 | ABUS | Arbutus Biopharma Corporation | 1.02B | 0.58% | 5,198,303 | 181.72M |
| 384 | FTH | Faeth Therapeutics, Inc. | 1.01B | -2.12% | 275,248 | - |
| 385 | CSTL | Castle Biosciences, Inc. | 1.00B | -0.46% | 216,737 | 357.28M |
| 386 | ANL | Adlai Nortye Group Ltd. | 998.81M | 3.33% | 308,574 | 18.06M |
| 387 | LXRX | Lexicon Pharmaceuticals, Inc. | 992.25M | -0.45% | 1,044,611 | 41.47M |
| 388 | AMPH | Amphastar Pharmaceuticals, Inc. | 975.40M | -1.08% | 650,129 | 730.02M |
| 389 | GERN | Geron Corporation | 970.13M | -3.82% | 11,478,945 | 204.56M |
| 390 | WVE | Wave Life Sciences, Inc. | 967.51M | 1.03% | 3,030,266 | 65.37M |
| 391 | SGP | SpyGlass Pharma, Inc. | 966.14M | -0.19% | 75,092 | - |
| 392 | CADL | Candel Therapeutics, Inc. | 964.13M | -1.41% | 535,822 | - |
| 393 | OLMA | Olema Pharmaceuticals, Inc. | 961.16M | 2.19% | 505,266 | - |
| 394 | DSGN | Design Therapeutics, Inc. | 953.12M | 0.59% | 774,800 | - |
| 395 | IMMX | Immix Biopharma, Inc. | 947.90M | -4.74% | 1,420,278 | - |
| 396 | ARDX | Ardelyx, Inc. | 939.44M | -0.26% | 2,982,312 | 450.89M |
| 397 | CBLL | CeriBell, Inc. | 932.97M | -1.66% | 223,607 | 101.96M |
| 398 | QDEL | QuidelOrtho Corporation | 917.54M | -4.22% | 890,257 | 2.67B |
| 399 | CLYM | Climb Bio, Inc. | 913.24M | 2.45% | 1,495,360 | - |
| 400 | HELP | Cybin Inc. | 905.22M | 1.39% | 1,026,782 | - |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 892.03M | -1.78% | 3,059,706 | 8.22M |
| 402 | TBPH | Theravance Biopharma, Inc. | 885.73M | -0.12% | 160,550 | 104.31M |
| 403 | ANNX | Annexon, Inc. | 885.33M | -4.11% | 1,227,542 | - |
| 404 | RIGL | Rigel Pharmaceuticals, Inc. | 884.87M | -2.67% | 104,968 | 276.79M |
| 405 | CBIO | Crescent Biopharma, Inc. | 875.71M | -2.01% | 647,211 | 11.88M |
| 406 | BBNX | Beta Bionics, Inc. | 870.10M | -0.41% | 1,407,468 | 119.01M |
| 407 | INMD | InMode Ltd. | 851.29M | -0.67% | 449,386 | 374.63M |
| 408 | AVR | Anteris Technologies Global Corp. | 840.09M | -4.65% | 362,900 | 2.24M |
| 409 | HSTM | HealthStream, Inc. | 839.77M | -1.64% | 203,456 | 321.12M |
| 410 | SIBN | SI-BONE, Inc. | 834.52M | 0.65% | 389,532 | 213.60M |
| 411 | AHCO | AdaptHealth Corp. | 825.80M | -4.62% | 2,614,813 | 3.36B |
| 412 | SLN | Silence Therapeutics plc | 824.27M | -6.17% | 611,151 | 615.00K |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 808.22M | -2.27% | 542,027 | 92.01M |
| 414 | ACHV | Achieve Life Sciences, Inc. | 806.76M | -7.66% | 886,366 | - |
| 415 | DBVT | DBV Technologies S.A. | 801.91M | -1.48% | 43,078 | 5.04M |
| 416 | PHAR | Pharming Group N.V. | 799.16M | 2.40% | 21,506 | 366.48M |
| 417 | CTMX | CytomX Therapeutics, Inc. | 795.33M | -1.62% | 1,984,748 | 18.30M |
| 418 | GLAS | Glass House Brands Inc. | 787.87M | -5.86% | 482,893 | 176.98M |
| 419 | NVCT | Nuvectis Pharma, Inc. | 781.63M | -2.04% | 117,165 | - |
| 420 | VREX | Varex Imaging Corporation | 779.32M | -0.11% | 676,537 | 865.00M |
| 421 | MPLT | MapLight Therapeutics, Inc. | 775.28M | 1.31% | 550,856 | - |
| 422 | MNPR | Monopar Therapeutics Inc. | 767.74M | -2.71% | 82,245 | - |
| 423 | AURA | Aura Biosciences, Inc. | 763.27M | -2.65% | 456,395 | - |
| 424 | NGNE | Neurogene Inc. | 763.03M | -1.22% | 205,633 | 925.00K |
| 425 | COLL | Collegium Pharmaceutical, Inc. | 760.82M | -0.68% | 901,142 | 808.21M |
| 426 | GYRE | Gyre Therapeutics, Inc. | 760.26M | 4.52% | 56,023 | 109.82M |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 752.69M | 2.22% | 1,139,803 | 136.07M |
| 428 | OCS | Oculis Holding AG | 750.66M | -0.08% | 124,347 | 1.45M |
| 429 | PHAT | Phathom Pharmaceuticals, Inc. | 749.03M | -0.74% | 1,236,691 | 239.66M |
| 430 | AGMB | AgomAb Therapeutics NV | 734.29M | -5.51% | 245,268 | - |
| 431 | VSTM | Verastem, Inc. | 731.75M | -1.46% | 2,301,509 | 87.53M |
| 432 | ASMB | Assembly Biosciences, Inc. | 718.32M | -3.61% | 156,451 | 74.85M |
| 433 | SOPH | SOPHiA GENETICS SA | 711.67M | 3.34% | 461,959 | 86.17M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.34M | -1.34% | 117,621 | - |
| 435 | BLSM | BlossomHill Therapeutics, Inc. | 702.66M | 4.18% | 168,706 | - |
| 436 | AHG | Akso Health Group | 699.76M | -3.68% | 2,649 | 13.83M |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 689.05M | -2.11% | 829,290 | 389.32M |
| 438 | MDXG | MiMedx Group, Inc. | 680.70M | 2.19% | 624,972 | 355.17M |
| 439 | SGMT | Sagimet Biosciences Inc. | 665.72M | -2.10% | 1,250,059 | - |
| 440 | DRUG | Bright Minds Biosciences Inc. | 656.68M | 2.69% | 65,007 | - |
| 441 | VALN | Valneva SE | 655.76M | -0.58% | 28,331 | 163.30M |
| 442 | SSII | SS Innovations International, Inc. | 655.26M | -4.11% | 21,845 | 52.40M |
| 443 | AQST | Aquestive Therapeutics, Inc. | 653.92M | -2.43% | 1,984,801 | 54.09M |
| 444 | EVO | Evotec SE | 653.69M | -2.15% | 121,907 | 819.47M |
| 445 | ALT | Altimmune, Inc. | 653.58M | -1.75% | 4,871,948 | 31.00K |
| 446 | STTK | Shattuck Labs, Inc. | 652.36M | -4.27% | 677,763 | 1.00M |
| 447 | STLN | Starling Oncology, Inc. | 644.11M | 6.58% | 1,775,412 | 587.24M |
| 448 | ALLO | Allogene Therapeutics, Inc. | 642.61M | -5.58% | 4,428,567 | 4.64M |
| 449 | CTEV | Claritev Corporation | 639.09M | -1.87% | 94,925 | 994.67M |
| 450 | CRMD | CorMedix Inc. | 637.58M | -2.97% | 792,913 | 462.25M |
| 451 | PHR | Phreesia, Inc. | 634.37M | -6.58% | 882,520 | 507.79M |
| 452 | PRME | Prime Medicine, Inc. | 633.34M | -3.78% | 1,619,295 | 4.07M |
| 453 | ANGO | AngioDynamics, Inc. | 629.08M | 0.13% | 527,438 | 320.17M |
| 454 | OABI | OmniAb, Inc. | 616.46M | -2.08% | 1,703,973 | 38.46M |
| 455 | PROK | ProKidney Corp. | 601.62M | -1.00% | 1,225,328 | 818.00K |
| 456 | CTKB | Cytek Biosciences, Inc. | 600.52M | -1.70% | 478,226 | 206.71M |
| 457 | CTNM | Contineum Therapeutics, Inc. | 599.68M | -4.55% | 346,230 | - |
| 458 | TECX | Tectonic Therapeutic, Inc. | 594.30M | -1.14% | 159,289 | - |
| 459 | ARVN | Arvinas, Inc. | 593.71M | -3.30% | 449,298 | 316.70M |
| 460 | SCTX | Scribe Therapeutics Inc. | 593.32M | 9.31% | 148,197 | 33.30M |
| 461 | TLRY | Tilray Brands, Inc. | 589.06M | -4.44% | 4,522,450 | 915.45M |
| 462 | ZURA | Zura Bio Limited | 587.43M | -1.61% | 1,620,260 | - |
| 463 | EOLS | Evolus, Inc. | 586.53M | -4.52% | 696,364 | 316.49M |
| 464 | WEAV | Weave Communications, Inc. | 584.79M | -0.27% | 2,193,936 | 257.79M |
| 465 | KIDS | OrthoPediatrics Corp. | 580.16M | -0.85% | 129,506 | 252.72M |
| 466 | EIKN | Eikon Therapeutics, Inc. | 580.11M | -1.38% | 238,698 | - |
| 467 | RGNX | REGENXBIO Inc. | 578.28M | -2.01% | 1,070,570 | 174.48M |
| 468 | BWAY | BrainsWay Ltd. | 566.93M | 0.07% | 49,630 | 60.70M |
| 469 | AUTL | Autolus Therapeutics plc | 561.60M | -5.80% | 1,836,156 | 117.39M |
| 470 | DCTH | Delcath Systems, Inc. | 557.96M | -2.43% | 180,916 | 95.42M |
| 471 | FLGT | Fulgent Genetics, Inc. | 555.81M | 2.38% | 374,988 | 323.93M |
| 472 | CABA | Cabaletta Bio, Inc. | 554.41M | -5.76% | 4,893,141 | - |
| 473 | PRLD | Prelude Therapeutics Incorporated | 545.87M | -2.93% | 257,583 | 22.42M |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 544.68M | -1.79% | 375,174 | - |
| 475 | OVID | Ovid Therapeutics Inc. | 537.07M | -1.79% | 1,066,037 | 1.58M |
| 476 | SPRY | ARS Pharmaceuticals, Inc. | 536.02M | -4.09% | 852,847 | 116.93M |
| 477 | ARTV | Artiva Biotherapeutics, Inc. | 531.92M | -2.77% | 168,592 | 251.00K |
| 478 | CAPR | Capricor Therapeutics, Inc. | 526.74M | -3.62% | 2,555,651 | 11.13M |
| 479 | ENTX | Entera Bio Ltd. | 521.16M | 0.33% | 824,562 | 42.00K |
| 480 | CERS | Cerus Corporation | 511.87M | -1.93% | 1,102,630 | 221.55M |
| 481 | NPCE | NeuroPace, Inc. | 506.63M | -0.94% | 92,320 | 106.99M |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 499.08M | -2.18% | 500,823 | - |
| 484 | SENS | Senseonics Holdings, Inc. | 493.31M | -3.12% | 425,575 | 48.55M |
| 485 | TCMD | Tactile Systems Technology, Inc. | 492.23M | -0.64% | 397,156 | 350.31M |
| 486 | PRTA | Prothena Corporation plc | 489.75M | -2.85% | 383,928 | 54.53M |
| 487 | PBYI | Puma Biotechnology, Inc. | 484.71M | -1.68% | 185,911 | 231.24M |
| 488 | EVH | Evolent Health, Inc. | 477.11M | -2.31% | 2,382,140 | 2.10B |
| 489 | KMDA | Kamada Ltd. | 476.16M | -2.93% | 160,809 | 191.85M |
| 490 | EVMN | Evommune, Inc. | 474.70M | 6.60% | 249,091 | 10.00M |
| 491 | SRTA | Strata Critical Medical, Inc. | 469.76M | -0.19% | 650,325 | 255.98M |
| 492 | NRC | NRC Health | 468.71M | -1.58% | 144,667 | 140.00M |
| 493 | DNA | Ginkgo Bioworks Holdings, Inc. | 467.34M | -0.14% | 1,078,094 | 132.42M |
| 494 | EDIT | Editas Medicine, Inc. | 465.35M | -6.19% | 1,390,713 | 47.01M |
| 495 | RZLT | Rezolute, Inc. | 459.65M | -3.93% | 867,084 | - |
| 496 | AVIR | Atea Pharmaceuticals, Inc. | 455.56M | -2.57% | 215,977 | - |
| 497 | RLMD | Relmada Therapeutics, Inc. | 453.35M | -4.06% | 1,697,000 | - |
| 498 | OCGN | Ocugen, Inc. | 451.02M | -2.21% | 3,567,525 | 4.58M |
| 499 | SGHT | Sight Sciences, Inc. | 446.21M | -2.99% | 102,466 | 83.38M |
| 500 | VOGX | Vogenx, Inc. | 445.36M | 0.85% | 89,617 | - |